HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of various laser wavelengths in the treatment of clinically significant macular edema in diabetics.

AbstractBACKGROUND AND OBJECTIVE:
To compare various laser wavelengths: argon green (514 nm), vs krypton red (647 nm), vs frequency doubled Nd:YAG (532 nm), and vs diode (810 nm), for laser photocoagulation treatment in clinically significant macular edema (CSME) in diabetics.
PATIENTS AND METHODS:
Four different wavelengths were used to sequentially treat 271 eyes of 164 diabetic patients with CSME. Follow up was conducted for a minimum of 6 months (9.8 +/- 1.3 months). Retreatment was performed if residual edema involving the foveal avascular zone persisted at 3 months.
RESULTS:
Reduction/elimination of CSME was observed in 93.3% of argon-treated eyes, 88.5% in krypton red group, 92.9% with frequency doubled Nd:YAG, and 84.8% with diode laser with no statistically significant difference between the groups (P > 0.05 for all groups). The number of eyes requiring retreatment was highest with the diode laser having 44.3% of eyes requiring retreatment and least with frequency doubled Nd:YAG having only 15.5% of eyes requiring retreatment (P = 0.0002).
CONCLUSIONS:
All lasers are equally effective in reducing/eliminating CSME. However, Nd:YAG may have an advantage because of requiring fewer retreatments.
AuthorsV Gupta, A Gupta, R Kaur, S Narang, M R Dogra
JournalOphthalmic surgery and lasers (Ophthalmic Surg Lasers) 2001 Sep-Oct Vol. 32 Issue 5 Pg. 397-405 ISSN: 1082-3069 [Print] United States
PMID11563784 (Publication Type: Case Reports, Comparative Study, Journal Article)
Topics
  • Adult
  • Diabetes Mellitus, Type 2 (complications)
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fundus Oculi
  • Humans
  • Laser Coagulation (methods)
  • Macular Edema (etiology, surgery)
  • Male
  • Middle Aged
  • Reoperation
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: